Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 01, 2026 02:00 ET | Source: Avacta Group PLC

Avacta presents updated clinical data showing encouraging early efficacy signals for AVA6000 in salivary gland cancers at ASCO 2026

Multiple confirmed partial and minor responses observed in patients with SGC Continuing very good safety profile, with removal of the lifetime maximum doxorubicin limit based on highly favorable...
June 01, 2026 02:00 ET | Source: Intravacc B.V.

Intravacc and Primrose Bio Renew Partnership to Enhance Conjugate Vaccine Development

Intravacc and Primrose Bio Renew Partnership to Enhance Conjugate Vaccine Development.
June 01, 2026 01:30 ET | Source: Biogen Inc.; UCB

UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus

Publication adds to previously reported findings from Phase 3 PHOENYCS GO study, demonstrating statistically significant improvement in disease activity at Week 48 with dapirolizumab pegol plus...
May 31, 2026 23:26 ET | Source: Shanghai East International Medical Center (SEIMC)

SEIMC Launches Precision Gallbladder-Preserving Treatment to Safeguard Biliary Health

SHANGHAI, May 31, 2026 (GLOBE NEWSWIRE) -- On March 14, 2026, Shanghai East International Medical Center (SEIMC) achieved a major milestone in global minimally invasive biliary treatment by...
May 31, 2026 19:30 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL

Ascentage Pharma Presents Data on Olverembatinib in CML-LBP and Ph+ BCP-ALL at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company...
May 31, 2026 19:30 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL

Ascentage Pharma Presents Its First Dataset on MDM2-p53 Inhibitor Alrizomadlin (APG-115) in Pediatric Solid Tumors at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company...
May 31, 2026 19:30 ET | Source: ASCENTAGE PHARMA GROUP INTERNATIONAL

Ascentage Pharma Presents Updated Clinical Data for Olverembatinib as Second-Line Therapy in CML-CP at ASCO 2026

ROCKVILLE, Md. and SUZHOU, China, May 31, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (NASDAQ: AAPG; HKEX: 6855), a global, commercial-stage, integrated biopharmaceutical company...
May 31, 2026 14:38 ET | Source: Glyco Harmony

Glyco Harmony Drops [URGENT REPORT 2026] GlycoHarmony Shocking Complete Scientific Breakdown of Benefits Everyone Is Talking

New York City, NY, May 31, 2026 (GLOBE NEWSWIRE) -- As awareness of metabolic health continues to rise worldwide, consumers are increasingly searching for products that can help support healthy...
May 31, 2026 13:24 ET | Source: SlimTide

SlimTide Capsules [SHOCKING REPORT 2026] Slim Tide Latest Viral Weight-Loss Supplement Craze, Counterfeit Market Explosion, and Consumer Safety Concerns

Slim Tide Capsules Reviews and Complaints: SlimTide Shocking Reveal What Consumers Need to Know About the Viral Weight Loss Supplement in 2026
May 31, 2026 10:00 ET | Source: Precede Biosciences, Inc.

Precede Biosciences Presents New ASCO 2026 Data Demonstrating Ability of Precede Bio Insight™ to Decode MET-Driven Biology and Resistance in Advanced NSCLC

Data include assessment of MET expression, tumor and immune pathway activity, and lineage plasticity from just 1 mL of plasma in advanced NSCLCPlasma MET test showed high concordance with tissue...